{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Anti-tubercular activity", "Dihydroartemisinin", "Ex vivo studies", "In-silico studies", "Multidrug-resistant TB", "Semi-synthetic derivatives."]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "30834834", "DateCompleted": {"Year": "2019", "Month": "07", "Day": "10"}, "DateRevised": {"Year": "2021", "Month": "09", "Day": "15"}, "Article": {"ArticleDate": [], "Language": ["eng"], "ELocationID": ["10.2174/1568026619666190305131425"], "Journal": {"ISSN": "1873-4294", "JournalIssue": {"Volume": "19", "Issue": "8", "PubDate": {"Year": "2019"}}, "Title": "Current topics in medicinal chemistry", "ISOAbbreviation": "Curr Top Med Chem"}, "ArticleTitle": "In Vitro, In Silico and Ex Vivo Studies of Dihydroartemisinin Derivatives as Antitubercular Agents.", "Pagination": {"StartPage": "633", "EndPage": "644", "MedlinePgn": "633-644"}, "Abstract": {"AbstractText": ["As a part of our drug discovery program for anti-tubercular agents, dihydroartemisinin (DHA-1) was screened against Mtb H37Rv, which showed moderate anti-tubercular activity (>25.0 \u00b5g/mL). These results prompted us to carry out the chemical transformation of DHA-1 into various derivatives and study their antitubercular potential.", "DHA-1 was semi-synthetically converted into four new acyl derivatives (DHA-1A - DHA-1D) and in-vitro evaluated for their anti-tubercular potential against Mycobacterium tuberculosis H37Rv virulent strain. The derivatives, DHA-1C (12-O-(4-nitro) benzoyl; MIC 12.5 \u00b5g/mL) and DHA-1D (12-O-chloro acetyl; MIC 3.12\u00b5g/mL) showed significant activity against the pathogen.", "In silico studies of the most active derivative (DHA-1D) showed interaction with ARG448 inhibiting the mycobacterium enzymes. Additionally, it showed no cytotoxicity towards the Vero C1008 cells and Mouse bone marrow derived macrophages.", "DHA-1D killed 62% intracellular M. tuberculosis in Mouse bone marrow macrophage infection model. To the best of our knowledge, this is the first-ever report on the antitubercular potential of dihydroartemisinin and its derivatives. Since dihydroartemisinin is widely used as an antimalarial drug; these results may be of great help in anti-tubercular drug development from a very common, inexpensive, and non-toxic natural product."], "CopyrightInformation": "Copyright\u00a9 Bentham Science Publishers; For any queries, please email at epub@benthamscience.net."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Medicinal Chemistry Department, CSIR-Central Institute of Medicinal and Aromatic Plants, Lucknow-226015, India."}], "LastName": "Kalani", "ForeName": "Komal", "Initials": "K"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Metabolic & Structural Biology Department, CSIR-Central Institute of Medicinal and Aromatic Plants, Lucknow- 226015, India."}], "LastName": "Alam", "ForeName": "Sarfaraz", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Microbiology Division, Central Drug Research Institute, Lucknow-226001, India."}], "LastName": "Chaturvedi", "ForeName": "Vinita", "Initials": "V"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Microbiology Division, Central Drug Research Institute, Lucknow-226001, India."}], "LastName": "Singh", "ForeName": "Shyam", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Metabolic & Structural Biology Department, CSIR-Central Institute of Medicinal and Aromatic Plants, Lucknow- 226015, India."}], "LastName": "Khan", "ForeName": "Feroz", "Initials": "F"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Medicinal Chemistry Department, CSIR-Central Institute of Medicinal and Aromatic Plants, Lucknow-226015, India."}], "LastName": "Srivastava", "ForeName": "Santosh Kumar", "Initials": "SK"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "United Arab Emirates", "MedlineTA": "Curr Top Med Chem", "NlmUniqueID": "101119673", "ISSNLinking": "1568-0266"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antitubercular Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Artemisinins"}, {"RegistryNumber": "6A9O50735X", "NameOfSubstance": "artenimol"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["chemistry", "pharmacology"], "DescriptorName": "Antitubercular Agents"}, {"QualifierName": ["chemistry", "pharmacology"], "DescriptorName": "Artemisinins"}, {"QualifierName": ["drug effects"], "DescriptorName": "Cell Survival"}, {"QualifierName": [], "DescriptorName": "Chlorocebus aethiops"}, {"QualifierName": [], "DescriptorName": "Computer Simulation"}, {"QualifierName": [], "DescriptorName": "Drug Discovery"}, {"QualifierName": [], "DescriptorName": "Models, Molecular"}, {"QualifierName": ["drug effects", "enzymology"], "DescriptorName": "Mycobacterium tuberculosis"}, {"QualifierName": [], "DescriptorName": "Protein Conformation"}, {"QualifierName": [], "DescriptorName": "Vero Cells"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2018", "Month": "12", "Day": "10"}, {"Year": "2019", "Month": "1", "Day": "14"}, {"Year": "2019", "Month": "1", "Day": "15"}, {"Year": "2019", "Month": "3", "Day": "6", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "7", "Day": "11", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "3", "Day": "6", "Hour": "6", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["30834834", "10.2174/1568026619666190305131425", "CTMC-EPUB-97062"]}}]}